<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00271141</url>
  </required_header>
  <id_info>
    <org_study_id>hy11/2005</org_study_id>
    <nct_id>NCT00271141</nct_id>
  </id_info>
  <brief_title>Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease</brief_title>
  <official_title>Multifunctional Substrate for Early Detection of Oxidative Stress Susceptibility and Application to Parkinson's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hillel Yaffe Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Technion, Israel Institute of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hillel Yaffe Medical Center</source>
  <brief_summary>
    <textblock>
      The proposed work is based on the detection of a novel molecule for sensitivity to oxidative
      stress in humans in venous blood
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Since alterations in mitochondrial functions in platelets and lymphocytes have been detected
      in Parkinson's disease we plan to monitor the metabolism a a new molecule (LTG) in the blood
      samples of Parkinson's disease patients and compare them to controls. We shall use 10 cc of
      venous blood and analyze serum, white blood cells and platelets. We shall not extract nor use
      DNA.The main purpose is to develop a marker for Parkinson's disease in venous blood.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>May 2005</start_date>
  <completion_date>December 2015</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <primary_purpose>Screening</primary_purpose>
    <time_perspective>Cross-Sectional, Retrospective</time_perspective>
  </study_design_info>
  <enrollment>500</enrollment>
  <condition>Parkinson's Disease</condition>
  <condition>Oxidative Stress</condition>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Parkinson's disease Healthy control -

        Exclusion Criteria:

        None -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rivka Inzelberg, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hillel Yaffe Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rivka Inzelberg, MD</last_name>
    <phone>+972-4-6304607</phone>
    <email>inzelberg@hy.health.gov.il</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hillel Yaffe Medical Center</name>
      <address>
        <city>Hadera</city>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Rivka Inzelberg, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>December 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2005</study_first_submitted>
  <study_first_submitted_qc>December 29, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 30, 2005</study_first_posted>
  <last_update_submitted>December 29, 2005</last_update_submitted>
  <last_update_submitted_qc>December 29, 2005</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 30, 2005</last_update_posted>
  <keyword>Parkinson's disease</keyword>
  <keyword>Oxidative stress</keyword>
  <keyword>Marker</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

